<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03852069</url>
  </required_header>
  <id_info>
    <org_study_id>B403201422056</org_study_id>
    <nct_id>NCT03852069</nct_id>
  </id_info>
  <brief_title>Inulin-type Fructans-rich Vegetables, Obesity, Gut Microbiota</brief_title>
  <acronym>Food4Gut</acronym>
  <official_title>Impact of a Diet Rich in Inulin-type Fructans Combined With Inulin Supplementation on Gut Microbiota Composition and Metabolic Parameters in Obese Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study was to evaluate the effect of a diet based on ITF-rich vegetables in
      combination with purified ITF supplementation on weight management, metabolic alteration and
      gut microbiota composition. Obese patients were treated for 3 months and several parameters
      were measured before and after the study period.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2016</start_date>
  <completion_date type="Actual">May 2018</completion_date>
  <primary_completion_date type="Actual">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gut microbiota composition</measure>
    <time_frame>Month 0 - Month 3</time_frame>
    <description>Relative abundance (%) of bacterial taxa will be assessed by 16S rRNA gene sequencing</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">106</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>16 g maltodextrin/day + recipes based on vegetables poor in inulin-type fructans</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inulin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>16 g inulin/day + recipes based on vegetables rich in inulin-type fructans</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Inulin</intervention_name>
    <description>Patient receive Inulin as dietary supplement (16g/d) in combination with dietary advice to enhance the consumption of inulin-rich vegetables</description>
    <arm_group_label>Inulin</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Patient receive maltodextrin as dietary supplement (16g/d) in combination with dietary advice to enhance the consumption of vegetables poor in inulin</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body mass index &gt; 30 kg/m²

          -  Caucasian

          -  Presence of at least one of the following comorbidity : prediabetes, diabetes,
             dyslipidemia, hypertension, steatosis.

        Exclusion Criteria:

          -  Psychiatric problems or use of antipsychotic

          -  Consumption of antibiotics, pro/prebiotics, fibre dietary supplement, or any molecules
             that modifies the intestinal transit (&lt;6 weeks)

          -  Pregnancy in progress or planified within 6 months

          -  Specific dietary practise (vegetarian, vegan,...)

          -  Specific dietary treatment (&lt;6 weeks) (e.g. high protein diet)

          -  Type 1 diabetes

          -  Excessive alcohol consumption (&gt;3 glasses/day)

          -  Inconclusive acceptability test (regarding the protocol of the intervention and the
             vegetables used in the protocol)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Paul Thissen, Pr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cliniques universitaires Saint-Luc- Université Catholique de Louvain</affiliation>
  </overall_official>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>February 21, 2019</study_first_submitted>
  <study_first_submitted_qc>February 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 22, 2019</study_first_posted>
  <last_update_submitted>March 1, 2019</last_update_submitted>
  <last_update_submitted_qc>March 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

